IL142301A0 - Benzamide derivatives as thrombin inhibitors - Google Patents

Benzamide derivatives as thrombin inhibitors

Info

Publication number
IL142301A0
IL142301A0 IL14230199A IL14230199A IL142301A0 IL 142301 A0 IL142301 A0 IL 142301A0 IL 14230199 A IL14230199 A IL 14230199A IL 14230199 A IL14230199 A IL 14230199A IL 142301 A0 IL142301 A0 IL 142301A0
Authority
IL
Israel
Prior art keywords
thrombin inhibitors
benzamide derivatives
benzamide
derivatives
thrombin
Prior art date
Application number
IL14230199A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL142301A0 publication Critical patent/IL142301A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14230199A 1998-10-03 1999-09-30 Benzamide derivatives as thrombin inhibitors IL142301A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9821483.6A GB9821483D0 (en) 1998-10-03 1998-10-03 Chemical compounds
PCT/EP1999/007194 WO2000020394A1 (en) 1998-10-03 1999-09-30 Benzamide derivatives as thrombin inhibitors

Publications (1)

Publication Number Publication Date
IL142301A0 true IL142301A0 (en) 2002-03-10

Family

ID=10839873

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14230199A IL142301A0 (en) 1998-10-03 1999-09-30 Benzamide derivatives as thrombin inhibitors

Country Status (21)

Country Link
US (2) US6441008B1 (ja)
EP (1) EP1117644A1 (ja)
JP (1) JP3457281B2 (ja)
KR (1) KR20010075546A (ja)
CN (1) CN1328548A (ja)
AR (1) AR023332A1 (ja)
AU (1) AU758007B2 (ja)
BR (1) BR9914267A (ja)
CA (1) CA2345997A1 (ja)
CO (1) CO5140085A1 (ja)
CZ (1) CZ20011216A3 (ja)
GB (1) GB9821483D0 (ja)
HU (1) HUP0103744A3 (ja)
IL (1) IL142301A0 (ja)
MA (1) MA26695A1 (ja)
NO (1) NO20011654L (ja)
NZ (1) NZ510839A (ja)
PE (1) PE20001059A1 (ja)
PL (1) PL347152A1 (ja)
TR (1) TR200100906T2 (ja)
WO (1) WO2000020394A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117144D0 (en) * 2001-07-13 2001-09-05 Glaxo Group Ltd Process
ES2377118T3 (es) 2004-09-21 2012-03-22 Trobio Ab Composición de proteasa estabilizada que comprende una serina proteasa, derivados de morfolino e inhibidores inversos de dicha serina proteasa
JP5080476B2 (ja) * 2005-09-22 2012-11-21 トルービオ・アーベー 安定化プロテアーゼ組成物
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW257757B (ja) 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
GB9406143D0 (en) 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic derivatives
GB9525620D0 (en) * 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
BR9914267A (pt) 2001-07-03
JP3457281B2 (ja) 2003-10-14
PE20001059A1 (es) 2000-10-23
PL347152A1 (en) 2002-03-25
AU758007B2 (en) 2003-03-13
HUP0103744A2 (hu) 2002-02-28
GB9821483D0 (en) 1998-11-25
HUP0103744A3 (en) 2002-03-28
NO20011654D0 (no) 2001-04-02
US6670381B2 (en) 2003-12-30
CA2345997A1 (en) 2000-04-13
NO20011654L (no) 2001-05-30
TR200100906T2 (tr) 2001-07-23
EP1117644A1 (en) 2001-07-25
NZ510839A (en) 2003-08-29
MA26695A1 (fr) 2004-12-20
CZ20011216A3 (cs) 2001-09-12
CN1328548A (zh) 2001-12-26
AU6467099A (en) 2000-04-26
KR20010075546A (ko) 2001-08-09
AR023332A1 (es) 2002-09-04
JP2002526531A (ja) 2002-08-20
US6441008B1 (en) 2002-08-27
CO5140085A1 (es) 2002-03-22
WO2000020394A1 (en) 2000-04-13
US20020169189A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
EP1124822A4 (en) THROMBIN INHIBITORS
PL349192A1 (en) Protease inhibitors
EP0969840A4 (en) THROMBIN INHIBITORS
GB9912961D0 (en) Metalloprotease inhibitors
EP0971891A4 (en) THROMBIN INHIBITORS
HK1040076A1 (zh) 作為整聯蛋白抑制劑的喹嗪酮
EP1079835A4 (en) PYRAZINONE AS THROMBINE INHIBITORS
EP1093367A4 (en) PROTEASE INHIBITORS
EP1117660A4 (en) THROMBIN INHIBITORS
PL350452A1 (en) Dihetero-substituted metalloprotease inhibitors
IL136139A0 (en) Thrombin inhibitors
PL349769A1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
EP1067894A4 (en) PROTHEASEINHIBITOREN
EP1079821A4 (en) PROTEASE INHIBITORS
EP1086083A4 (en) PROTEASE INHIBITORS
EP1140897A4 (en) PROTEASE INHIBITORS
IL142301A0 (en) Benzamide derivatives as thrombin inhibitors
EP1017383A4 (en) THROMBIN INHIBITORS
PL346022A1 (en) Isoquinolines as urokinase inhibitors
EP1189618A4 (en) thrombin
EP1039907A4 (en) THROMBIN INHIBITORS
EP1027333A4 (en) THROMBIN INHIBITORS
GB9806034D0 (en) Thrombin inhibitors
GB9809784D0 (en) Thrombin Inhibitors
GB9807941D0 (en) Thrombin inhibitors